Vimarsana
Biggest News Aggregation in the World

Contract Pharmacies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contract Pharmacies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contract Pharmacies Today - Breaking & Trending Today

From Your Delegate: Legislative disappointments and successes - Vimarsana News

From Your Delegate: Legislative disappointments and successes

Week 9 of the second regular session of the 86th Legislature … adjourned Sine Die (Latin for “Without a day specified for a future meeting; indefinitely”).

Source: wvnews.com
California Prohibits PBM Discriminatory Practices Against 340B Program Covered Entities and Contract Pharmacies | Hinshaw & Culbertson - Health Care - Vimarsana News

California Prohibits PBM Discriminatory Practices Against 340B Program Covered Entities and Contract Pharmacies | Hinshaw & Culbertson - Health Care

The 340B Drug Program requires pharmaceutical manufacturers participating in the Medicaid program to provide covered outpatient drugs at significantly reduced prices to certain health...

AJMC® in the Press, July 28, 2023 - Vimarsana News

AJMC® in the Press, July 28, 2023

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Source: ajmc.com
340B Litigation Updates Week Ending March 13 2023 - Vimarsana News

340B Litigation Updates Week Ending March 13 2023

How are 340B cases developing across the country? Defendant in a state law case has filed a motion to dismiss the case. The court in a contract pharmacy case involving an anti-trust cause of action granted the defendant’s motion to dismiss.

Third Circuit Ruling Allows Restrictions on 340B Contract Pharmacies | Bass, Berry & Sims PLC - Vimarsana News

Third Circuit Ruling Allows Restrictions on 340B Contract Pharmacies | Bass, Berry & Sims PLC

On January 30, the U.S. Court of Appeals for the Third Circuit issued a unanimous decision in favor of drug manufacturers, finding that manufacturer restrictions on the use of contract...